Buflomedil hydrochloride (CAS 35543-24-9)
QUICK LINKS
Buflomedil hydrochloride is a compound that functions as a vasodilator by inhibiting phosphodiesterase activity, leading to an increase in intracellular cyclic adenosine monophosphate (cAMP) levels. This increase in cAMP levels results in relaxation of smooth muscle cells in blood vessels, leading to vasodilation. By targeting phosphodiesterase activity, buflomedil hydrochloride modulates the cellular signaling pathways involved in vascular tone regulation. Buflomedil hydrochloride′s mode of action involves its interaction with phosphodiesterase enzymes, which are responsible for the degradation of cAMP. By inhibiting these enzymes, buflomedil hydrochloride effectively increases cAMP levels, leading to vasodilation and improved blood flow. This mechanism of action makes buflomedil hydrochloride a relevant compound for studying the regulation of vascular tone and its potential implications in experimental.
Buflomedil hydrochloride (CAS 35543-24-9) References
- Assessment of collateral perfusion: a pharmacodynamic study with buflomedil hydrochloride. | Labs, KH., et al. 2000. Angiology. 51: 301-8. PMID: 10779000
- Protective effect of buflomedil in a rat model of moderate cerebral ischemia. | Briguglio, FS., et al. 2005. Arzneimittelforschung. 55: 437-42. PMID: 16149710
- Gas chromatographic-mass spectrometric analysis of buflomedil hydrochloride in biological samples after acute intoxication. | De Giovanni, N. and Fucci, N. 1991. Forensic Sci Int. 51: 125-9. PMID: 1752588
- Interpenetrating polymer network of locust bean gum-poly (vinyl alcohol) for controlled release drug delivery. | Kaity, S., et al. 2013. Carbohydr Polym. 94: 456-67. PMID: 23544563
- Preparation and evaluation of a buflomedil hydrochloride niosomal patch for transdermal delivery. | Akhtar, N., et al. 2015. J Liposome Res. 25: 191-201. PMID: 25357198
- Metabolic effects of buflomedil hydrochloride. | Briguglio, F., et al. 1985. J Int Med Res. 13: 131-58. PMID: 2989026
- Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases. | Clissold, SP., et al. 1987. Drugs. 33: 430-60. PMID: 3297620
- Controlled simultaneous iontophoresis of buflomedil hydrochloride and dexamethasone sodium phosphate to the mucosa for oral submucous fibrosis. | Tyagi, V., et al. 2021. Int J Pharm. 607: 121009. PMID: 34391856
- Effects of buflomedil hydrochloride in occlusive arterial disease of the lower limbs stage IV. | Briguglio, F., et al. 1986. J Int Med Res. 14: 115-23. PMID: 3721052
- Determination of buflomedil hydrochloride [2',4',6'-trimethoxy-4-(pyrrolidinyl)butyrophenone hydrochloride] by reversed-phase ion-pair high-performance liquid chromatography. | Badmin, JA., et al. 1979. J Chromatogr. 172: 319-25. PMID: 548535
- [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies]. | Tallarida, G., et al. 1983. Cardiologia. 28: 651-60. PMID: 6687209
- Buflomedil hydrochloride attenuates tourniquet-induced microvascular reperfusion injury in striated muscle. | Menger, MD., et al. 1994. Int J Microcirc Clin Exp. 14: 296-302. PMID: 7705991
- Buflomedil hydrochloride reduces systemic activation of polymorphonuclear leukocytes during hyperdynamic endotoxemia. | Holzer, K., et al. 1998. Shock. 10: 335-42. PMID: 9840648
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Buflomedil hydrochloride, 1 g | sc-234225 | 1 g | $36.00 |